by PMH Genesis Cell | Dec 10, 2020 | News & Resources
Abstract Premature ovarian failure is a relatively common condition that affects 1–3% of adult women. Premature ovarian failure occurs when there is loss of ovarian function in women younger than 40 years of age. The causes are mostly iatrogenic or idiopathic....
by PMH Genesis Cell | Dec 1, 2020 | News & Resources
Abstract Mesenchymal stem cells (MSCs) are multipotent non-haematopoietic progenitor cells that are being explored as a promising new treatment fortissue regeneration. Although their immunomodulatory properties are not yet completely understood, their low immunogenic...
by PMH Genesis Cell | Dec 1, 2020 | News & Resources
Abstract The World Health Organization estimates that diabetes will be the fourth most prevalent disease by 2050. Developing a new therapy for diabetes is a challenge for researchers and clinicians in field. Many medications are being used for treatment of diabetes...
by PMH Genesis Cell | Dec 1, 2020 | News & Resources
Abstract Degenerative joint disease presents inherent complexity with treatment because of itsprogressive nature, and as a result, there are limited options for definitive treatment.Mesenchymal stem cells (MSCs) have been implicated in treatment of such...
by PMH Genesis Cell | Dec 1, 2020 | News & Resources
Abstract Chronic low back pain affects approximately 632 million people worldwide with prevalence as high as 68% in adults older than 60 years of age (1,2). It has both substantial social and economic impacts on patients and healthcare budgets resulting in the highest...
by PMH Genesis Cell | Dec 1, 2020 | News & Resources
Abstract Introduction Current cell therapy for cartilage regeneration requires invasive procedures, periosteal coverage and scaffold use. We have developed a novel transplantation method withsynovial mesenchymal stem cells (MSCs) to adhere to the cartilage defect....
